HIV Medicine

Article	Citations
Issue Information	85
	81
Issue Information	79
	74
The characteristics of men who have sex with men (MSM) using post‐exposure prophylaxis for sexual exposure (PEPSE) in the pre‐exposure prophylaxis (PrEP) era	50
	44
Loneliness and social isolation in people with HIV aged ≥50 years. The No One Alone (NOA)‐GeSIDA study conducted by the GeSIDA 12021 study group	42
Issue Information	42
Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends	37
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV‐specific risk factors; the Archi‐Prevaleat project	37
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co‐administration	35
Areas with high HIV prevalence: A spatial analysis of nationwide claims data in Germany	29
Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms	29
HIV cure: Are we going to make history?	28
Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina	28
IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study	28
The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV	27
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany	25
Reflections on a specialist HIV menopause service	25
Disparities in HIV continuum of care in the paediatric population: A real‐life study in Brazil	25
Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV	23
Effect of an opt‐out point‐of‐care HIV‐1 nucleic acid testing intervention to detect acute and prevalent HIV infection in symptomatic adult outpatients and reduce HIV transmission in Kenya: a randomiz	22
	21
Issue Information	19
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of non‐tuberculous mycobacteria 2024	19

Using an automated decision support tool to improve HIV prescribing: A feasibility study	19
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process	16
Assessment of targeted intervention programme under the National AIDS Control Program among men who have sex with men in India	16
The effect of HIV and mpox co‐infection on clinical outcomes: Systematic review and meta‐analysis	16
Exploring the cascade of mental healthcare among people with HIV experiencing depressive symptoms in the UK and Ireland: The POPPY study	16
Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004–2020: A surveillance study	14
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium	14
Associations between HIV infection and frailty status and its individual components: Are frailty components disproportionally affected?	14
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy	14
Immune reconstitution inflammatory syndrome‐associated Graves disease in HIV‐infected patients: clinical characteristics and response to radioactive iodine therapy	14
Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119	14
Are there additional adverse effects of testosterone use among men living with HIV?—Data from the PUSH! study	14
Efficacy of an electronic reminder for HIV screening in primary healthcare based on indicator conditions in Catalonia (Spain)	13
Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care	13
The value of herpes zoster prevention in people aging with HIV: A narrative review	13
Influence of physical activity on endothelial function in people living with HIV	13
No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people withHIV with profound immunosuppression	13
The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study	13
	12
Special issue on Women and HIV to mark International Women’s Day	12
	12
Microbial translocation is associated with advanced liver fibrosis among people with HIV	12
Urinary biomarkers of early renal injury in antiretroviral‐naïve HIV‐positive persons in Shanghai, China: comparison with the general population	12
HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature	12
	12
Increasing HIV early diagnosis by implementing an automated screening strategy in emergency departments	11
Access to care and impact on HIV treatment interruptions during the COVID‐19 pandemic among people living with HIV in British Columbia	11
Issue Information	11
Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV (ANRS CO4	11
Issue Information	11
AI in medicine: No longer the future, but the present	11
Knowledge and HIV‐related stigma among Portuguese healthcare professionals: A cross‐sectional analysis	10
	10
An updated systematic review of HIV‐associated cryptococcal meningitis treatment strategies	10
Predictors of poor health‐related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project	10
“Editorial comment on: Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study”	10
Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors	10
HCV incidence in people with HIV in southwest China: A retrospective cohort study (2004–2023)	10
Oral Abstracts	10
	10
	10
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study	9
The role of HIV as a risk modifier for coronary endothelial function in young adults	9
Issue Information	9
Virtual care pathways for people living with HIV: A mixed‐methods systematic review	9
Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases	9
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection	9
Author Index	9
Author Index	9
Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV	9

Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy	9
Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care	9
Issue Information	9
Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study	9
Biomarkers of inflammation and coagulation predict non‐AIDS‐defining events in a prospective cohort of virologically suppressed people living with HIV	9
Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda	8
Themed Posters	8
Immune response to ART initiation in advanced HIV infection	8
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review	8
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV‐1 vaccine formulations	8
Frailty and frailty screening: A qualitative study to elicit perspectives of people living with HIV and their healthcare professionals	8
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)	8
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study	8
“Real world” efficacy of bulevirtide in HBV/HDV‐related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spa	8
Anticholinergic medications associated with falls and frailty in people with HIV	8
Incidence and predictors of attrition from HIV treatment among adults living with HIV in high‐caseload facilities following implementation of universal test and treat strategy in	8
Characterization of HIV‐1 drug resistance among patients with failure of second‐line combined antiretroviral therapy in central Ethiopia	8
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV	8
British HIV Association guidelines for the management of HIV‐2 2021	7
Spatial and temporal trends in HIV/AIDS burden among South Asian countries from 1990 to 2021: A systematic examination of the Global Burden of Disease study 2021	7
Late diagnosis of HIV: An updated consensus definition	7
	7
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study	7
‘We want it all’:ARTpreferences assessed byDesirability ofOutcomeRanking	7
Managing cardiovascular risk in people living with HIV in Asia – where are we now?	7
Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak	7
Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial	7
Issue Information	7
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross‐sectional analysis in Chongqing, China	7
Issue Information	7
Study of natural product adverse events in adult HIV‐infected patients in Canada	7
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV	7
Issue Information	7
Assessing weight change in adolescents and young adults with perinatally acquired HIV and integrase inhibitor use	7
Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV	7
Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey	6
Frailty and sarcopenia among Turkish people aged 40 and above living with HIV	6
	6
Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment	6
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis	6
Sleep deficiency among people living with human immunodeficiency virus: A growing challenge	6
High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence	6
Longitudinal analysis of new‐onset non‐AIDS‐defining diseases among people living with HIV: A real‐world observational study	6
Issue Information	6
Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta‐analysis	6
Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with	6
Optimizing statin prescriptions for people living with HIV: Evidence for improved communication and shared care between primary care and specialist HIV services	6
Potential drug–drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey	6
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)	6
CROI 2024 BHIVA working group summary	6
Issue Information	6
One for all, all for one: neuro‐HIV multidisciplinary platform for the assessment and management of neurocognitive complaints in people living with HIV	6
Clinical outcomes of HIV–syphilis coinfection among patients with no neurological symptoms: a retrospective cohort study	6
Impact of the COVID‐19 pandemic on the HIV care continuum and associated factors in middle‐income countries: A mixed‐methods systematic review	6
Factors influencing the quality of life and social skills of children living with HIV: A case–control study	6
Trends in preterm birth in women living with HIV in Switzerland over the last three decades: A multicentric, prospective, cohort study	6
Positive Outcomes: Validity, reliability and responsiveness of a novel person‐centred outcome measure for people with HIV	6
Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing	6
Implementation of frailty screening for older people living with HIV in Brighton, UK	6
Intergenerational sex and early sexual debut are associated with HIV infection among transgender women in Paraguay	6
	6
Long‐term outcomes for children and adolescents with Kaposi sarcoma	5
Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies	5
	5
HIV and fracture: Risk, assessment and intervention	5
	5
No overall impact on rate of weight gain with integrase inhibitor‐containing regimens in antiretroviral‐naïve adults	5
Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis	5
Issue Information	5
Issue Information	5
Correction to ‘Abstracts of the 19th European AIDS Conference (#EACS2023), October 18–21, 2023, Warsaw, Poland’	5
Cost of non‐communicable diseases in people living with HIV in the Central Denmark Region	5
	5
	5
	5
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts	5
Cardiac adiposity as a modulator of cardiovascular disease in HIV	5
Abstracts	5
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)	5
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV‐1 initiating first‐line therapy: 5‐year follow‐up from two phase III stud	5

Sexually transmitted and blood‐borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: Findings from a Canadian pragmatic rand	5
Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin‐based regimen: A retrospective observational case series	5
Issue Information	5
	5
Erratum	5
Issue Information	5
What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study	5
Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort	5
Issue Information	5
	5
Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression	5
Issue Information	4
Taxonomic and functional profile of the anorectal microbiota in HIV‐positive and HIV‐negative men who have sex with men, using a metagenomic approach	4
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96	4
Collection of menopause data in studies of women living with HIV: A systematic literature review	4
	4
Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV	4
Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat	4
Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial	4
Issue Information	4
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population‐based cohort study	4
Strategies for strengthening same‐day ART initiation, tracing people living with HIV lost to follow‐up and viral load monitoring mechanisms in Ethiopia	4
Issue Information	4
	4
No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria	4
Immunological and virological response to initial antiretroviral therapy among older people living with HIV in the Canadian Observational Cohort (CANOC)	4
Advanced HIV disease: A review of diagnostic and prophylactic strategies	4
	4
Antiretroviral drug switches to zidovudine‐based regimens and loss to follow‐up during the first COVID‐19 lockdown in Bali, Indonesia	4
HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems	4
Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020	4
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021	4
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real‐life experience from a French cohort (2019–2023)	4
BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia‐Pacific region	4
People with HIV have a higher risk of COVID‐19 diagnosis but similar outcomes to the general population	4
Rapid HIV pre‐exposure prophylaxis (PrEP) initiation is safe and feasible: Experience from Wroclaw All Saints cohort in Poland 2017–2021	4
A new year, and big changes for HIV Medicine	4
Real‐world experience with weight gain among pregnant women living with HIV who are using integrase inhibitors	4
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study	4
PrEP for women in Europe: a systematic literature review	4
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (	4
Issue Information	4
Failure to return pillbox is a predictor of being lost to follow‐up among people living with HIV on antiretroviral therapy in rural Tanzania	4
The spectrum of kidney biopsy findings in Chinese HIV‐infected patients	4
Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial	4
Frailty in people 50 years or older living with HIV: A sex perspective	4
Late diagnosis of HIV in 2022: Why so little change?	4
Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms	4
Loss to follow‐up among human immunodeficiency virus‐positive postpartum women and its predictive factors: A retrospective study	4
	3
The use of non‐invasive imaging modalities for the assessment of skeletal muscle quantity and quality in people with HIV: A narrative review	3
High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study	3
HIV disease hospitalizations and factors associated with in‐hospital mortality in Ecuador: A nationwide analysis from 2015 to 2023	3
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV	3
Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’	3
People with HIV and healthcare workers views on screening for cognitive impairment in people with HIV: A qualitative study	3
	3
	3
Breaking down global barriers: A multinational and multi‐community approach to combat stigma and enhance mental wellbeing in people with HIV	3
	3
	3
Correction to “Perception of medical care among women living with HIV aged 40 years or older—a European‐wide survey”	3
Snapshot of clinical problems among people living with HIV in China	3
Themed Poster Abstracts	3
Prevalence of osteoporosis in people living with HIV and risk factors associated in the cART era	3
Dolutegravir in real life: Self‐reported mental and physical health outcomes after transitioning from efavirenz‐ to dolutegravir‐based antiretroviral therapy in a prospective cohort study in Lesotho	3
The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta‐analyses and systematic reviews and the construction of a hypothetic	3
Issue Information	3
Network analysis to prioritize issues for intervention to improve the health‐related quality of life of people with HIV in Spain	3
HIV pre‐exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID)	3
Transitions in treatment: A systematic review and meta‐aggregation of preferences and barriers in switching from oral to long‐acting injectable antiretroviral therapy among people living with HIV	3
	3
Issue Information	3
Issue Information	3
Issue Information	3
Oral abstracts	3
A call for health systems to monitor the health‐related quality of life of people living with HIV	3
A qualitative study of perspectives, experiences and priority outcomes for people living with HIV and frailty	3
Patients re‐engaging with HIV care in Guatemala: Prioritizing CD4 counting and screening for histoplasmosis and tuberculosis	3
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohort	3
Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on	3
British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 2024	3
Clinically recognized sleep disorders in people living with HIV	3
Outcomes of persistent low‐level viremia among HIV patients on antiretroviral therapy: A prospective cohort study	3
Late diagnosis of HIV among Ukrainian refugees in the Czech Republic: A retrospective, observational study	3
The incidence of and risk factors for hospitalized acute kidney injury among people living with HIV on antiretroviral treatment	3
Poster Abstracts	3
Clinical staff attitudes towards opt‐out consent for blood‐borne virus screening in emergency departments in England	3
Metabolic syndrome and Pathobiological Determination of Atherosclerosis in Youth risk score in adolescents with and without perinatally acquired HIV in the Cape Town Adolescent and Antiretr	3
Comparing effectiveness of first‐line antiretroviral therapy between peri‐urban and rural clinics in KwaZulu‐Natal, South Africa	3
No overall impact on body mass index for age change after dolutegravir initiation in a French paediatric cohort	2
Real‐world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV‐1 aged over 50 years who are virologically suppressed	2
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group and more recen	2
No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy	2
Voluntary counselling and testing points (VCTs) in Poland as a complementary and accessible alternative to public healthcare facilities: A comparative analysis of epidemiological data from	2